Induction Healthcare Group PLC Result of AGM

RNS Number : 3022A

Induction Healthcare Group PLC

13 August 2024

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Results of 2024 Annual General Meeting ("AGM")

London, UK - 13 August 2024: Induction Healthcare Group PLC ("Induction", the "Company", or the "Group"; AIM: INHC), a leading digital health platform driving transformation of healthcare systems, held its AGM today at 50 Liverpool Street, London EC2M 7PY at 10.00am (BST).

 

The poll results on each resolution proposed are available on the Company website.

 

All Ordinary Resolutions were passed.

 

 

Enquiries

 

Induction Christopher Samler, Chair Paul Tambeau, Chief Executive Officer	[phone] [phone]
Singer Capital Markets (Nominated Adviser and Broker)	[phone]
Philip Davies Alaina Wong Jalini Kalaravy

 

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions that transforms care delivery and the patient journey through hospital. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGSFAFEDELSEEA